Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand Products For National Distribution

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has signed a major multi-company acquisition agreement that will boost revenues, strengthen pharmaceutical operations and our management team. These additions will enhance our internal operations and help to fast track our full line of Cannabis Science Brand pharmaceutical and over the counter products through multiple distribu

Feed Date: 
February 14, 2012